| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,791 |
9,891 |
$616K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,760 |
3,989 |
$182K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,330 |
3,769 |
$19K |
| 80305 |
|
2,277 |
2,028 |
$17K |
| 99490 |
Ccm add 20min |
1,935 |
1,799 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,415 |
1,002 |
$13K |
| 80061 |
Lipid panel |
1,881 |
1,645 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
627 |
594 |
$9K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
102 |
101 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
632 |
332 |
$8K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
73 |
66 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
280 |
264 |
$7K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
66 |
65 |
$7K |
| 82947 |
|
4,020 |
3,319 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
3,517 |
3,043 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
340 |
309 |
$5K |
| 92551 |
|
634 |
588 |
$4K |
| 81003 |
|
3,464 |
3,028 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
171 |
147 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
898 |
793 |
$3K |
| 93000 |
|
296 |
279 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
211 |
198 |
$3K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
104 |
55 |
$2K |
| 90682 |
|
147 |
112 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
15 |
12 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$1K |
| 99173 |
|
608 |
561 |
$986.51 |
| 90686 |
|
70 |
67 |
$646.07 |
| 94060 |
|
20 |
16 |
$638.17 |
| 86308 |
|
112 |
108 |
$606.25 |
| 99457 |
|
54 |
54 |
$410.23 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
66 |
65 |
$168.44 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
15 |
13 |
$167.64 |
| 99497 |
|
33 |
30 |
$88.30 |
| 99439 |
|
14 |
14 |
$78.78 |
| 99454 |
|
15 |
15 |
$69.15 |
| 99458 |
|
12 |
12 |
$66.40 |
| G0008 |
Administration of influenza virus vaccine |
189 |
145 |
$42.04 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
84 |
70 |
$7.58 |
| 90658 |
|
14 |
14 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,103 |
881 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
248 |
218 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
170 |
153 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
174 |
138 |
$0.00 |
| 90662 |
|
33 |
14 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
24 |
24 |
$0.00 |
| 3051F |
|
16 |
15 |
$0.00 |
| 1100F |
|
55 |
27 |
$0.00 |
| 3288F |
|
81 |
32 |
$0.00 |
| 3061F |
|
486 |
398 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
385 |
277 |
$0.00 |
| 3044F |
|
37 |
36 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
39 |
33 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
127 |
113 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
17 |
14 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
53 |
41 |
$0.00 |